Sartorius Stedim Biotech (DIMN) Ratios
Sartorius Stedim Biotech Ratios
MX:DIMN's free cash flow for Q3 2026 was $-25.70M. For the 2026 fiscal year, MX:DIMN's free cash flow was decreased by $-89.50M and operating cash flow was $63.80M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.02 | 1.85 | 1.51 | 1.61 | 1.40 |
| Quick Ratio | 0.53 | 1.12 | 0.57 | 0.62 | 0.65 |
| Cash Ratio | 0.30 | 0.72 | 0.12 | 0.10 | 0.22 |
| Solvency Ratio | 0.15 | 0.11 | 0.11 | 0.41 | 0.25 |
| Operating Cash Flow Ratio | 0.38 | 0.87 | 0.67 | 0.59 | 0.67 |
| Short-Term Operating Cash Flow Coverage | 0.97 | 20.58 | 10.91 | 136.07 | 27.29 |
| Net Current Asset Value | $ -2.45B | $ -2.49B | $ -3.65B | $ -880.00M | $ -762.24M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.32 | 0.35 | 0.48 | 0.22 | 0.16 |
| Debt-to-Equity Ratio | 0.64 | 0.72 | 1.40 | 0.46 | 0.38 |
| Debt-to-Capital Ratio | 0.39 | 0.42 | 0.58 | 0.32 | 0.27 |
| Long-Term Debt-to-Capital Ratio | 0.31 | 0.40 | 0.57 | 0.29 | 0.24 |
| Financial Leverage Ratio | 1.96 | 2.07 | 2.93 | 2.07 | 2.39 |
| Debt Service Coverage Ratio | 1.07 | 3.17 | 3.73 | 23.74 | 16.14 |
| Interest Coverage Ratio | 3.60 | 2.33 | 4.00 | 24.27 | 65.71 |
| Debt to Market Cap | 0.12 | 0.15 | 0.16 | 0.04 | 0.01 |
| Interest Debt Per Share | 28.28 | 31.29 | 41.27 | 12.77 | 6.90 |
| Net Debt to EBITDA | 2.51 | 3.27 | 4.72 | 0.77 | 0.49 |
| Profitability Margins | |||||
| Gross Profit Margin | 45.33% | 43.41% | 44.44% | 52.52% | 53.79% |
| EBIT Margin | 18.50% | 13.27% | 18.70% | 32.90% | 23.22% |
| EBITDA Margin | 29.22% | 24.12% | 27.23% | 38.10% | 28.12% |
| Operating Profit Margin | 18.50% | 13.33% | 17.46% | 28.49% | 23.67% |
| Pretax Profit Margin | 12.58% | 7.88% | 14.45% | 32.36% | 22.40% |
| Net Profit Margin | 8.95% | 6.30% | 11.16% | 25.08% | 14.35% |
| Continuous Operations Profit Margin | 8.96% | 6.42% | 11.24% | 25.19% | 14.35% |
| Net Income Per EBT | 71.17% | 79.88% | 77.21% | 77.50% | 64.08% |
| EBT Per EBIT | 67.98% | 59.15% | 82.79% | 113.59% | 94.65% |
| Return on Assets (ROA) | 3.31% | 2.12% | 4.00% | 17.30% | 10.49% |
| Return on Equity (ROE) | 6.49% | 4.39% | 11.74% | 35.77% | 25.03% |
| Return on Capital Employed (ROCE) | 8.31% | 5.06% | 7.12% | 24.70% | 23.45% |
| Return on Invested Capital (ROIC) | 5.44% | 4.09% | 5.48% | 19.11% | 14.82% |
| Return on Tangible Assets | 7.38% | 4.71% | 9.80% | 28.70% | 16.94% |
| Earnings Yield | 1.30% | 0.96% | 1.40% | 3.14% | 0.93% |
| Efficiency Ratios | |||||
| Receivables Turnover | 13.06 | 10.42 | 9.45 | 8.34 | 7.77 |
| Payables Turnover | 5.84 | 5.08 | 5.97 | 6.59 | 5.31 |
| Inventory Turnover | 2.35 | 2.30 | 1.75 | 1.62 | 1.70 |
| Fixed Asset Turnover | 1.47 | 1.47 | 1.70 | 2.70 | 3.11 |
| Asset Turnover | 0.37 | 0.34 | 0.36 | 0.69 | 0.73 |
| Working Capital Turnover Ratio | 7.14 | 4.34 | 4.99 | 6.63 | 7.95 |
| Cash Conversion Cycle | 120.91 | 122.00 | 186.30 | 213.96 | 192.47 |
| Days of Sales Outstanding | 27.96 | 35.03 | 38.62 | 43.75 | 47.00 |
| Days of Inventory Outstanding | 155.45 | 158.89 | 208.87 | 225.58 | 214.23 |
| Days of Payables Outstanding | 62.51 | 71.92 | 61.19 | 55.36 | 68.76 |
| Operating Cycle | 183.41 | 193.92 | 247.49 | 269.32 | 261.23 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 5.54 | 8.42 | 6.83 | 6.64 | 7.55 |
| Free Cash Flow Per Share | 1.49 | 4.91 | 1.69 | 1.97 | 4.04 |
| Dividend Paid and CapEx Coverage Ratio | 1.17 | 2.00 | 1.04 | 1.12 | 1.80 |
| Capital Expenditure Coverage Ratio | 1.37 | 2.40 | 1.33 | 1.42 | 2.15 |
| Operating Cash Flow Coverage Ratio | 0.21 | 0.28 | 0.17 | 0.54 | 1.11 |
| Operating Cash Flow to Sales Ratio | 0.18 | 0.29 | 0.23 | 0.18 | 0.24 |
| Free Cash Flow Yield | 0.71% | 2.60% | 0.71% | 0.65% | 0.84% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 76.92 | 104.29 | 71.27 | 31.82 | 107.30 |
| Price-to-Sales (P/S) Ratio | 6.89 | 6.57 | 7.95 | 7.98 | 15.40 |
| Price-to-Book (P/B) Ratio | 5.00 | 4.58 | 8.37 | 11.38 | 26.85 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 140.53 | 38.42 | 141.40 | 153.44 | 119.54 |
| Price-to-Operating Cash Flow Ratio | 37.94 | 22.40 | 35.05 | 45.53 | 63.89 |
| Price-to-Earnings Growth (PEG) Ratio | 1.51 | -2.26 | -1.10 | 0.29 | 4.54 |
| Enterprise Value Multiple | 26.07 | 30.50 | 33.93 | 21.72 | 55.26 |
| Enterprise Value | 22.61B | 20.45B | 25.64B | 28.91B | 44.87B |
| EV to EBITDA | 26.07 | 30.50 | 33.93 | 21.72 | 55.26 |
| EV to Sales | 7.62 | 7.36 | 9.24 | 8.28 | 15.54 |
| EV to Free Cash Flow | 155.48 | 43.03 | 164.24 | 159.10 | 120.62 |
| EV to Operating Cash Flow | 41.97 | 25.09 | 40.71 | 47.21 | 64.47 |
| Tangible Book Value Per Share | -3.03 | -5.33 | -20.78 | 5.43 | 2.47 |
| Shareholders’ Equity Per Share | 42.04 | 41.19 | 28.63 | 26.58 | 17.96 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.29 | 0.19 | 0.22 | 0.22 | 0.36 |
| Revenue Per Share | 30.50 | 28.73 | 30.12 | 37.90 | 31.32 |
| Net Income Per Share | 2.73 | 1.81 | 3.36 | 9.51 | 4.50 |
| Tax Burden | 0.71 | 0.80 | 0.77 | 0.78 | 0.64 |
| Interest Burden | 0.68 | 0.59 | 0.77 | 0.98 | 0.96 |
| Research & Development to Revenue | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 |
| SG&A to Revenue | 0.22 | 0.23 | 0.06 | 0.04 | 0.04 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.03 | 3.72 | 2.03 | 0.54 | 1.08 |
Currency in EUR